Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Carter Bankshares Inc. CARE

Carter Bankshares Inc is a holding company. The Company is the parent company of its wholly-owned subsidiary, Carter Bank & Trust. The bank is focused on serving the banking needs of small-to-medium-sized businesses, professional concerns, and individuals. It offers business banking services, including business checking, business debit cards, and other banking services, including notary services, wire transfer services, night depository services, and others. It offers personal banking services, including passbook savings, personal debit cards, telephone banking, money orders, and others.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

CIBC downgrade

Dialogue Health Technologies (TSE:CARE) was downgraded by analysts at CIBC from an "outperform" rating to a "neutral" rating. They now have a C$4.00 price target on the stock, down...read more

Desjardins - cantechletter

Dialogue Health receives target trim from Desjardins By Geordie Carragher Published on May 13, 2022 Last Updated on May 13, 2022 Filed under:   All posts, Analysts, Health Stock:  ...read more

two analysts

Dialogue Health Technologies (TSE:CARE) had its price target lowered by analysts at Scotiabank from C$11.00 to C$8.50.This represents a 120.2% upside from the current price of C$3.86.  ...read more

Laurentian Bank - cantechletter

Dialogue Health Technologies scores a target raise from Laurentian Bank By Geordie Carragher Published on April 14, 2022 Last Updated on April 14, 2022 Filed under...read more

Laurentian Bank -cantechletter.com

  Pro Stock Picks Search All Software Cannabis Fintech ...read more

newer Desjardins comment cantechletter

  Dialogue Health Technologies is a double, says Desjardins By Geordie Carragher Published on February 23, 2022 Last Updated on February 23, 2022 Filed...read more

Canadian Stocks that could explode in 2022

Dialogue amongst the pack!  rate and reply

Desjardins comment- cantechletter

By Geordie Carragher December 1, 2021 Filed under:   All posts, Analysts, Health Stock:   care Dialogue Health Technologies gets a vote of confidence, Desjardins reports...read more

Sunlife has an opinion

  Possibleidiot01 Reputation: 811   ...read more

Sun Life strengthens investment in virtual care

Done at a premium to the market Sun Life strengthens investment in virtual care Canada NewswireDec 1, 2021 9:00 AM EST Sun Life acquires additional common shares of...read more

There goes Dialogue !

Canadian stocks that could explode  rate and reply

This company has so much cash...

Its embarrasing. They could start buying or just expanding with no need to go to market for more money for a long time. May we please go back up to 12$????  rate and reply

RE:NEVER TRUST ANALYSTS TARGETS

Tesla's book value per share is 26 bucks. Companies are valued based on their assets and the revenue/profit they generate in a forward looking context. CARE is massively undervalued and it...read more

NEVER TRUST ANALYSTS TARGETS

DIALOGUE issued its 1st IPO of 8,334,000 common shares  at $12/share.  It now has a float of 65,768,407 common shares. A syndicate of 10 underwriters (way too many) took part in...read more

Q3 report

This stock despite bank ratings over 10$ has not inspired any buying. I really hope they have a positive bombshell to drop that brings attention back. Almost zero news since IPO.   rate and reply

Dialogue featured

As one of best telehealth stocks!  6 Telehealth Stocks to Buy  rate and reply

HELLLLLOOOO MGMT<<<

Just a friendly reminder that you have smaller shareholders who would very much like to hear how how business is going? Your competitors are doing alot.....  rate and reply

RE:RE:RE:Made the List

The sad part is some of this could have been avoided if they had not given away so many cheap options and if they had been more open with news on a more regular basis. I may jump back in when it hits...read more

RE:RE:Made the List

There's no incentive to buy because no one is driving up the price. The smart people are putting in their buys at lower and lower prices waiting for existing shareholders to give up and capitulate...read more

RE:Made the List

Well all the awards in the world will not help shareholders if the Board does not start taking responsibility and taking management to task. If they wait 2 months again to say anything they really are...read more
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >